financetom
Business
financetom
/
Business
/
UK's JD Sports confident on forecasts after first-half beat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UK's JD Sports confident on forecasts after first-half beat
Oct 2, 2024 10:44 PM

LONDON, Oct 2 (Reuters) - British sportswear retailer JD

Sports Fashion beat a consensus forecast for first-half

profit and said it was on track to meet annual guidance, showing

its multi-brand strategy working at a time when Nike ( NKE ) is

struggling.

The FTSE 100-listed group, which sells Nike ( NKE ), Adidas, On,

HOKA and other brands in Britain, Europe and the United States,

said on Wednesday it would meet targets, despite what it called

a competitive and promotional marketplace.

Nike ( NKE ) on Tuesday posted disappointing quarterly

sales growth and

warned

its holiday season would likely to be filled with

discounts.

For the 26 weeks to Aug. 3, JD Sports posted adjusted

pretax profit of 405.6 million pounds ($538.35 million), ahead

of analyst expectations of 384 million pounds.

"Our success is a direct reflection of the strength and

agility of our global, multi-brand strategy, which allows us to

adapt swiftly to fast-changing industry trends across the

world," Chief Executive Regis Schultz said in a statement.

The group also reiterated its guidance for annual profit

of between 955 million pounds and 1.035 billion pounds.

($1 = 0.7534 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval
Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval
Jun 25, 2024
04:41 AM EDT, 06/25/2024 (MT Newswires) -- Halozyme Therapeutics ( HALO ) said Tuesday that Roche received European Commission marketing authorization of OCREVUS SC co-formulated with ENHANZE, Halozyme's proprietary recombinant human hyaluronidase enzyme, for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis. OCREVUS SC is a 10-minute injection that maintains the same twice-yearly schedule as the approved...
OpenAI to cut access to tools for developers in China and other regions, Chinese state media says
OpenAI to cut access to tools for developers in China and other regions, Chinese state media says
Jun 25, 2024
BEIJING, June 25 (Reuters) - ChatGPT maker OpenAI is planning to block access to technology used to build artificial intelligence products for entities in China and some other countries, a Chinese state-owned newspaper reported on Tuesday. ChatGPT is not available in mainland China but many Chinese startups have been able to access OpenAI's application programming interface (API) platform and use...
Novo Nordisk's Wegovy weight-loss drug approved in China
Novo Nordisk's Wegovy weight-loss drug approved in China
Jun 25, 2024
SHANGHAI (Reuters) -Novo Nordisk said on Tuesday its popular weight-loss drug Wegovy has been approved in China, paving the way for sales in the world's second-largest economy. Novo said in March that it would initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. The company did not immediately respond to a Reuters request for comment on...
--Nvidia Shares Attempt Rebound Premarket Tuesday After Closing 6.7% Lower Monday
--Nvidia Shares Attempt Rebound Premarket Tuesday After Closing 6.7% Lower Monday
Jun 25, 2024
04:47 AM EDT, 06/25/2024 (MT Newswires) -- Price: 116.57, Change: +0.93, Percent Change: +0.84 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved